Table 7. Effect of the duration of chemotherapy on morbidity and mortality n=(%) following hepatic resection for colorectal liver metastasis.
Duration of chemotherapy
|
|||||
---|---|---|---|---|---|
Control | <3 m | 3–6 m | >6 m | ||
Outcome | n=245 | n=13 | n=216 | n=18 | P-value * |
Any morbidity | 66 (27%) | 4 (31%) | 61 (28%) | 7 (39%) | 0.487 |
Life-threatening complications | 13 (5%) | 0 (0%) | 11 (5%) | 3 (17%) | 0.438 |
Medical complications | 53 (22%) | 4 (31%) | 55 (26%) | 4 (22%) | 0.373 |
Surgical complications | 22 (9%) | 0 (0%) | 9 (4%) | 3 (17%) | 0.230 |
Mortality | 5 (2%) | 0 (0%) | 3 (1%) | 2 (11%) | 0.645 |
χ2 test for trend.
In n=5 (2%) patients the duration of chemotherapy was not recorded.